Code of Ethics

Lusofarmaco operates in a complex and ever-changing market, interacting with many stakeholders such as healthcare professionals, patients, government and public structures, and suppliers.

This context sets up a high profile of social and moral responsibility that dictates a framework of values based on ethics, transparency, business integrity, high professional quality and a clear focus on service. The company aims to underline the importance of these basic principles through the adoption of its own Code of Ethics.

This Code in line with the Group's Code of Conduct and with the deontological rules of Farmindustria is an integral part of the company's Model pursuant to Legislative Decree 231/01. Every employee must respect and enforce the Code and strengthen its application through compliant and responsible conduct.

Code of Ethic - PDF

Menarini Group Code of Conduct: integrity and ethics are the foundations of our actions

The Menarini Group Code of Conduct expresses the values that inspire our Group in its work. In no way may the intention of operating in the interest of Menarini, or a direct or indirect subsidiary, justify the adoption of conduct which contradicts the principles contained in this Code of Conduct.

We are convinced that constantly placing integrity and ethics at the foundation of our actions is the source of our strength and the key to ever-increasing success.

This code is not just a collection of words on a sheet of paper, but a direct, concrete guide to inspire the conduct of directors, managers and employees in Italy and abroad, as well as a commitment towards collective based on conscious actions with regard to our stakeholders.

The Menarini Group Code of Conduct is applicable for all Group companies, wherever they are located in the world.

Code of Conduct - PDF

THE GENERAL PRINCIPLES OF CONDUCT


Download the General Principles of Conduct

 

Reporting Channels to the Supervisory Body

Istituto Luso Farmaco d’Italia spa has set up dedicated whistleblowing channels (as listed below) to the 231 Supervisory Body for encouraging any reporting of potential violations of the 231/2001 Model and/or relevant offences pursuant to Legislative Decree 231/2001:

  • certified e-mail: odv.lusofarmaco@legalmail.it
  • e-mail: odvlusofarmaco@lusofarmaco.it
  • ordinary mail: Supervisory Body, LusoFarmaco spa, Milanofiori, Strada 6 edificio L, 20089, Rozzano (MI).

 

The report will be handled with the utmost confidentiality and protection from any kind of retaliation and/or discriminatory behaviour of anyone who, in good faith, makes a report.

Our products

Lusofarmaco can claim extensive know-how in various therapeutic areas: cardiovascular and respiratory diseases, antibiotic therapy, neuropsychiatry and gynecology.

Research & Development

For many years, Lusofarmaco has been mainly a national company, with a portfolio focused on well-established medicinal products, which have been the reference drugs in their respective therapeutic areas.

Pharmacovigilance

Pharmacovigilance: what does it mean to monitor drugs?

Registered Office:
Milanofiori – Strada 6, Edificio L – 20089 Rozzano (MI)
Tel. 02-516555.1

Registration No. In Registrar Of Companies: 00714810157
Registrar Of Companies' Office: Milano
Registered Capital: € 130.000 I.V.
Capital Reported In Last Financial Statement: € 130.000
Company subject to the direction and coordination of A. Menarini Industrie Farmaceutiche Riunite Srl

SITEMAP

Copyright 2024 Istituto Lusofarmaco D'Italia S.p.A.